Li Mi
Impact in
-
- Signaling Pathways in Disease
- Genomics, phytochemicals, and oxidative stress
- RNA modifications and cancer
-
- Galectins and Cancer Biology
Papers in
-
- Natural product bioactivities and synthesis 2
- DNA Repair Mechanisms 1
- Glycosylation and Glycoproteins Research 1
- Cell death mechanisms and regulation 1
-
- Galectins and Cancer Biology 1
- Co-authors
- Wenshuang Wu (7 shared papers)Zhichao Xing (7 shared papers)Jinliang Xing (2 shared papers)Jian‐Li Jiang (2 shared papers)Rong Tian (1 shared paper)Qiang Feng (1 shared paper)Ping Zhu (1 shared paper)Zhi‐Nan Chen (1 shared paper)
In The Last Decade
Li Mi
16 papers receiving 289 citations
Peers
Comparison fields: 5 of 70
- Molecular Biology 177
- Immunology 49
- Cancer Research 32
- Hepatology 13
- Oncology 38
Countries citing papers authored by Li Mi
This map shows the geographic impact of Li Mi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Mi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Mi more than expected).
Fields of papers citing papers by Li Mi
This network shows the impact of papers produced by Li Mi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Mi. The network helps show where Li Mi may publish in the future.
Co-authors
The 25 scholars most cited alongside Li Mi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 135 | |
| 2 | 2022 | 37 | |
| 3 | 2022 | 34 | |
| 4 | 2023 | 14 | |
| 5 | 2022 | 13 | |
| 6 | 2025 | 12 | |
| 7 | 2024 | 9 | |
| 8 | 2023 | 9 | |
| 9 | 2024 | 7 | |
| 10 | 2023 | 6 | |
| 11 | 2001 | 5 | |
| 12 | 2024 | 3 | |
| 13 | 2018 | 2 | |
| 14 | 2025 | 1 | |
| 15 | 2020 | 1 | |
| 16 | 2025 | 1 | |
| 17 | 2025 | 0 |
About Li Mi
Li Mi is a scholar working on Molecular Biology, Immunology, Pathology and Forensic Medicine, Epidemiology and Cancer Research, having authored 17 papers that have together received 289 indexed citations. Recurring topics across this work include Natural product bioactivities and synthesis (2 papers), Cancer Mechanisms and Therapy (2 papers), DNA Repair Mechanisms (1 paper), Glycosylation and Glycoproteins Research (1 paper), Galectins and Cancer Biology (1 paper), Cholinesterase and Neurodegenerative Diseases (1 paper), Liver physiology and pathology (1 paper) and Cell death mechanisms and regulation (1 paper). The work is most often cited by research in Molecular Biology (177 citations), Immunology (49 citations), Cancer Research (32 citations), Hepatology (13 citations) and Oncology (38 citations). Li Mi has collaborated with scholars based in China, Japan and Macao. Frequent co-authors include Wenshuang Wu, Zhichao Xing, Jinliang Xing, Jian‐Li Jiang, Rong Tian, Qiang Feng, Ping Zhu, Zhi‐Nan Chen, Xiang-Min Yang and Yang Zhang. Their work appears in journals such as Journal of Cancer Survivorship, Applied Optics, Proceedings of the National Academy of Sciences, Planta Medica and Journal of Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.